drugset / Trial / NCT02539134
TAK-935 Multiple Rising Dose Study in Healthy Participants
RandomizedParallel-groupQuadruple-blindOther
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of multiple rising doses of TAK-935 in healthy participants.
Timeline
- Start
- 2015-09
- Primary completion
- 2016-04
- Completion
- 2016-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Soticlestat | Small molecule | 100 mg | Oral |
| Subject | Soticlestat | Small molecule | 300 mg | Oral |
| Subject | Soticlestat | Small molecule | 400 mg | Oral |
| Subject | Soticlestat | Small molecule | 600 mg | Oral |